TNF and IL‐6 are potent growth factors for OH‐2, a novel human myeloma cell line
Data up to Jan 2025
Total Citations Per Year
Abstract
References (37)
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
1983 • 26,063 citations
Genomic sequencing.
1984 • 8,343 citations
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
1988 • 1,698 citations
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
1986 • 1,282 citations
Production of hybridoma growth factor by human monocytes
1987 • 1,133 citations
Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.
1968 • 833 citations
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
1989 • 775 citations
Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
1990 • 678 citations
TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES
1988 • 282 citations
Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma
1989 • 271 citations
Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.
1990 • 263 citations
Response patterns of purified myeloma cells to hematopoietic growth factors
1989 • 231 citations
Serum-free in vitro bioassay for the detection of tumor necrosis factor
1986 • 195 citations
Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266
1991 • 177 citations
Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.
1989 • 163 citations
Production of cytokines by bone marrow cells obtained from patients with multiple myeloma
1989 • 156 citations
Diagnosis of Nasopharyngeal Carcinoma by DNA Amplification of Tissue Obtained by Fine-Needle Aspiration
1992 • 143 citations
Selective expression of CD45 isoforms defines CALLA+ monoclonal B- lineage cells in peripheral blood from myeloma patients as late stage B cells
1991 • 129 citations
Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
1989 • 107 citations
Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features
1987 • 105 citations
In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma
1991 • 91 citations
Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features
1987 • 85 citations
Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease
1991 • 85 citations
Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta
1993 • 77 citations
Lack of IL‐1 secretion from human myeloma cells highly purified by immunomagnetic separation
1993 • 64 citations
Two new IgA1-kappa plasma cell leukaemia cell lines (JJN-1 & JJN-2) which proliferate in response to B cell stimulatory factor 2.
1989 • 60 citations
Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma
1988 • 59 citations
Direct cloning of specific genomic DNA sequences in plasmid libraries following fragment enrichment
1985 • 59 citations
p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia
1992 • 54 citations
A rapid and sensitive immunoassay for tumor necrosis factor using magnetic monodisperse polymer particles
1990 • 52 citations
Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
1991 • 48 citations
Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell lines
1989 • 42 citations
Autocrine Growth by Two Cytokines, Interleukin-6 and Tumor Necrosis Factor Alpha, in the Myeloma Cell Line KHM-1A
1990 • 31 citations
Establishment and characterization of four myeloma cell lines which are responsive to interleukin-6 for their growth.
1991 • 27 citations
Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line.
1988 • 21 citations
Human tumour necrosis factors-α and -β: Differences in their structure, expression and biological properties
1990 • 18 citations
Establishment and characterization of a plasma cell leukaemia cell line dependent for growth on IL‐6 and a bi‐phenotypic subclone dependent upon both IL‐3 and IL‐6
1991 • 8 citations